GLP-1 Also Known As Semaglutide
GLP-1 (glucagon-like peptide-1) receptor agonists, such as Semaglutide, are a class of medications originally developed for the treatment of type 2 diabetes but have also gained recognition for their role in weight management. Semaglutide mimics the action of the naturally occurring hormone GLP-1, which is involved in the regulation of blood sugar levels and appetite. By activating GLP-1 receptors, Semaglutide enhances insulin secretion in response to meals, suppresses glucagon release (a hormone that raises blood sugar levels), and slows gastric emptying. These combined effects help to lower blood sugar levels and reduce appetite, leading to improved glycemic control and potential weight loss.
Semaglutide has shown significant promise in clinical trials for weight management. It helps reduce body weight by promoting feelings of satiety and fullness, leading to decreased calorie intake. This has made it an attractive option for individuals with obesity or those struggling with weight management, even in the absence of diabetes. At Thrive Medical Spa, the medication is administered once weekly, making it a convenient option for many patients. However, like all medications, individuals need to consult with one of our Thrive providers to understand the potential benefits and risks, and to determine if Semaglutide is the right option for their specific health needs.
Semaglutide for weight management, follows a slightly different dosing schedule than for Type-2 diabetes. Initiation and Titration: The treatment starts at a low dose and is increased gradually over 16 to 20 weeks to the target dose. Patients on Semaglutide should have regular follow-ups with our Thrive Medical Spa provider to monitor blood glucose levels, weight, and any potential side effects. Adjustments to the dosing regimen may be necessary based on individual response and tolerance.